pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,879 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT03465774: Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions

    Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Pleural Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07393074: PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC)

    Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Hepato Cellular Carcinoma, Cirrhosis, Autonomic Nervous System, Central Nervous System

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05054010: Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants

    Sponsor: Tethis S.p.A.. Phase: . Conditions: Breast Neoplasms

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02076113: Cervical Spondylotic Myelopathy Surgical Trial

    Sponsor: Lahey Clinic. Phase: NA. Conditions: Cervical Spondylosis With Myelopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07455760: Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients

    Sponsor: Boston University Charles River Campus. Phase: NA. Conditions: Parkinson's Disease (PD), Essential Tremor

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07495020: The Laparoscopic Transit Bipartition With Use Metalic Anastomosis Clip

    Sponsor: The Society of Bariatric and Metabolic Surgeons of Kazakhstan. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity & Overweight, Marginal Ulcer (Peptic) or Erosion, Leakage, Anastomotic

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05014282: Automated Video-Assisted Smoking Treatment for People Living With HIV

    Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: NA. Conditions: Smoking Cessation

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07298759: The Effect of Hydroxytyrosol Administration on Superoxide Dismutase, Pulsatility Index and Resistance Index of Uterine Artery Doppler and Flow-Mediated Dilatation of Brachial Artery In Mothers With Hypertension In Pregnancy

    Sponsor: Dr Cipto Mangunkusumo General Hospital. Phase: NA. Conditions: Hypertension in Pregnancy

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07262580: The Feasibility of an Intervention Targeting Sources of Meaning in Cardiac Rehabilitation

    Sponsor: University of Southern Denmark. Phase: NA. Conditions: Heart Disease, Mental Health Outcomes, Rehabilitation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05263674: Fast Acute Sedation at Intensive Care vs. High-dose i.v. Anti-seizure Medication for Treatment of Non-convulsive Status Epilepticus (FAST-trial)

    Sponsor: University of Southern Denmark. Phase: PHASE3. Conditions: Non-Convulsive Status Epilepticus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07452718: Effests of Minimalist Footwear on Healthy Subjects.

    Sponsor: University of Salamanca. Phase: NA. Conditions: Healthy Adult Participants

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06751290: The Use of Cyproheptadine in Pediatric Feeding Disorders

    Sponsor: University of Miami. Phase: PHASE4. Conditions: Pediatric Feeding Disorder, Chronic, Avoidant Restrictive Food Intake Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05417490: Factors Influencing Participation in PRADO and Telemedicine Interventions in Heart Failure

    Sponsor: University Hospital, Montpellier. Phase: . Conditions: Heart Failure

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05869760: Baylor Infant and Toddler Biomarker of Nutrition Study

    Sponsor: Baylor College of Medicine. Phase: . Conditions: Healthy Nutrition, Healthy Diet

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05222620: SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

    Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07563582: Efficacy of Oral Sucrosomial Iron Supplementation in Children With Celiac Disease and Iron Deficiency or Anemia

    Sponsor: Istituto Giannina Gaslini. Phase: NA. Conditions: Celiac Disease in Children, Anemia, Iron Deficiencies

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07310082: Allograft vs. Autograft Nonunion

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Nonunion Fracture

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05360680: A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

    Sponsor: Cue Biopharma. Phase: PHASE1. Conditions: Colorectal Cancer, Gastric Cancer, Pancreatic Cancer, Ovarian Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07514546: Investigation of The Effect of Video-Assisted Laughter Yoga

    Sponsor: Ataturk University. Phase: NA. Conditions: Laughter Yoga

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07041346: The Effect of Gender Education Provided to Health Sciences Students on Gender Perception and Roles

    Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: EDUCATION

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06360588: Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Malignant Solid Neoplasm

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04320888: Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Hematopoietic and Lymphatic System Neoplasm, Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma, Recurrent Histiocytic and Dendritic Cell Neoplasm, Recurrent Langerhans Cell Histiocytosis, Recurrent Lymphoma, Recurrent Malignant Germ Cell Tumor, Recurrent Malignant Glioma, Recurrent Malignant Solid Neoplasm, Recurrent Medulloblastoma, Recurrent Neuroblastoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Osteosarcoma, Recurrent Peripheral Primitive Neuroectodermal Tumor, Recurrent Rhabdoid Tumor, Recurrent Rhabdomyosarcoma, Recurrent Soft Tissue Sarcoma, Recurrent WHO Grade 2 Glioma, Refractory Ependymoma, Refractory Ewing Sarcoma, Refractory Hepatoblastoma, Refractory Histiocytic and Dendritic Cell Neoplasm, Refractory Langerhans Cell Histiocytosis, Refractory Lymphoma, Refractory Malignant Germ Cell Tumor, Refractory Malignant Glioma, Refractory Malignant Solid Neoplasm, Refractory Medulloblastoma, Refractory Neuroblastoma, Refractory Non-Hodgkin Lymphoma, Refractory Osteosarcoma, Refractory Peripheral Primitive Neuroectodermal Tumor, Refractory Rhabdoid Tumor, Refractory Rhabdomyosarcoma, Refractory Soft Tissue Sarcoma, Refractory WHO Grade 2 Glioma, Wilms Tumor

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07295288: Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis

    Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Synkinesis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07245303: Neural Mechanisms of Light Driven Analgesia

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Musculoskeletal Pain, Fibromyalgia, Healthy Controls Group - Age and Sex-matched

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06657261: Comparison of the Analgesic Efficacy of Chest Wall Blocks in Coronary Artery Bypass Surgery

    Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Coronary Arterial Disease (CAD), Serratus Anterior Muscle Plane Block, Transversus Thoracis Muscle Plane Block, Postoperative Analgesia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07347327: The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke

    Sponsor: Ke Dong, MD. Phase: NA. Conditions: Aphasia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05705427: The COMBAT HBV Feasibility Trial

    Sponsor: University of North Carolina, Chapel Hill. Phase: PHASE4. Conditions: Hepatitis B, Vertical Transmission of Infectious Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07272486: The Use of Virtual Reality and Music Therapy for Hypertensive Urgency

    Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Hypertensive Urgency, Primary Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07285642: Brain and Peripheral Muscle Oxygenation in Patients With Chronic Obstructive Pulmonary Disease

    Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Copd

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07368270: Safety and Efficacy Study of Anti-PD1 Armored CD19 CAR-T Cells in Adult Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma

    Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Diffuse Large B Cell Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05474170: Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest

    Sponsor: Geneve TEAM Ambulances. Phase: NA. Conditions: Cardiopulmonary Arrest, Pediatric ALL, Resuscitation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07513870: Comparing Inhalational Anesthesia and TIVA on Maternal and Neonatal Hemodynamics in Elective Cesarean Section

    Sponsor: Medipol University. Phase: NA. Conditions: Cesarean Section, Anesthesia, General, Anesthesia, Intravenous

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04963283: Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

    Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Colorectal Adenocarcinoma, Colon Cancer, Colon Adenocarcinoma, Rectum Cancer, Rectal Cancer, Rectal Adenocarcinoma, Colorectal Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07311083: Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy

    Sponsor: Kliniken Essen-Mitte. Phase: NA. Conditions: Microbiome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00506441: A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

    Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Chronic Kidney Disease, Dialysis, Hyperphosphatemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07423741: Ultrasonographical Assessment of Airway Indices in Pregnancy

    Sponsor: South Valley University. Phase: . Conditions: Airway Assessment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07181941: Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma

    Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE1. Conditions: Recurrent Multiple Myeloma, Refractory Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05478694: Outcomes of Focal Ablation for Prostate Cancer

    Sponsor: University of Texas Southwestern Medical Center. Phase: . Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07161466: Effects of Positive End-Expiratory Pressure Levels on Lung Recruitment Duration and Hemodynamics After Alveolar Recruitment Maneuver: A Randomized Clinical Trial

    Sponsor: Northern Jiangsu People's Hospital. Phase: NA. Conditions: Dynamic Lung Compliance, Alveolar Recruitment Maneuver

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00544466: Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

    Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Leukemia, Myelodysplastic Syndromes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07362550: Effects of 12-Week Balanced Diet on Body Composition & Metabolic Parameters in Twins

    Sponsor: University of Veterinary and Animal Sciences, Lahore - Pakistan. Phase: NA. Conditions: Healthy Adults

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04802291: HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity

    Sponsor: Rutgers, The State University of New Jersey. Phase: NA. Conditions: Healthy Lifestyle, Home Environment Related Disease, Cognitive Change, Child Behavior, Child Obesity, Parenting, Parents, Parent-Child Relations

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06575374: Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Cell Therapy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07109297: Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India

    Sponsor: Sanofi. Phase: PHASE4. Conditions: RSV Immunization

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07150260: Correlation Between Carotid Stump Pressure and Interhemispheric rSO₂ Asymmetry During Awake Carotid Endarterectomy

    Sponsor: Izmir Katip Celebi University. Phase: . Conditions: Carotid Artery Stenosis Symptomatic, Carotid Endarterectomy (CEA) Surgical Patients, Cerebral Hypoperfusion

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05903560: Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion

    Sponsor: Jinling Hospital, China. Phase: NA. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07318220: Prehabilitation Protocol for Head and Neck Cancer Patients

    Sponsor: University of Miami. Phase: NA. Conditions: Head and Neck Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07482020: SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism

    Sponsor: Huashan Hospital. Phase: PHASE2. Conditions: Atrial Fibrillation (AF), Hypertension

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03843359: A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

    Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Neoplasms

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04980404: Inqovi Maintenance Therapy in Myeloid Neoplasms

    Sponsor: Massachusetts General Hospital. Phase: PHASE1. Conditions: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Stem Cell Leukemia

    full page →ctgov ↗
    ← prev
    page 16 of 98
    next →